Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METOCLOPRAMIDE Cause Atrioventricular block first degree? 12 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Atrioventricular block first degree have been filed in association with METOCLOPRAMIDE (metoclopramide hydrochloride). This represents 0.1% of all adverse event reports for METOCLOPRAMIDE.

12
Reports of Atrioventricular block first degree with METOCLOPRAMIDE
0.1%
of all METOCLOPRAMIDE reports
0
Deaths
12
Hospitalizations

How Dangerous Is Atrioventricular block first degree From METOCLOPRAMIDE?

Of the 12 reports, 12 (100.0%) required hospitalization, and 1 (8.3%) were considered life-threatening.

Is Atrioventricular block first degree Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METOCLOPRAMIDE. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does METOCLOPRAMIDE Cause?

Nausea (1,080) Drug ineffective (927) Off label use (926) Drug hypersensitivity (751) Vomiting (672) Dyspnoea (525) Headache (499) Diarrhoea (481) Hypersensitivity (473) Tardive dyskinesia (465)

What Other Drugs Cause Atrioventricular block first degree?

FINGOLIMOD (285) AMLODIPINE (148) METOPROLOL (120) BISOPROLOL (98) FLECAINIDE (98) OMEPRAZOLE (94) AMIODARONE (85) VERAPAMIL (84) DILTIAZEM (79) FUROSEMIDE (78)

Which METOCLOPRAMIDE Alternatives Have Lower Atrioventricular block first degree Risk?

METOCLOPRAMIDE vs METOLAZONE METOCLOPRAMIDE vs METOPIMAZINE METOCLOPRAMIDE vs METOPROLOL METOCLOPRAMIDE vs METRELEPTIN METOCLOPRAMIDE vs METRONIDAZOLE

Related Pages

METOCLOPRAMIDE Full Profile All Atrioventricular block first degree Reports All Drugs Causing Atrioventricular block first degree METOCLOPRAMIDE Demographics